Arrowhead Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2013
Total Assets: $37.3M
Liabilities Breakdown FY2013
Total Liabilities: $9.8M
Asset Breakdown
Total Assets: $37.3M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $19.1M | 51.2% |
| Accounts Receivable | $75.0K | 0.2% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $3.5M | 9.4% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $3.2M | 8.7% |
| Other Assets | $11.4M | 30.5% |
Liabilities Breakdown
Total Liabilities: $9.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.2M | 12.2% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $8.6M | 87.8% |